3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Hemangiosarcoma
1
HER2-positive Breast Cancer
1
Colorectal Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma
1
Interventions
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Metastatic Breast Cancer
×
tucatinib
×
30 days
×
Clear all
No trials found.